USA stockpiling of remdesivir: How should the world respond?
J Comp Eff Res
; 9(18): 1243-1246, 2020 12.
Article
in English
| MEDLINE | ID: covidwho-2256422
ABSTRACT
The race to find an effective treatment for coronavirus disease 2019 (COVID-19) is still on, with only two treatment options currently authorized for emergency use and/or recommended for patients hospitalized with severe respiratory symptoms low-dose dexamethasone and remdesivir. The USA decision to stockpile the latter has resulted in widespread condemnation and in similar action being taken by some other countries. In this commentary we discuss whether stockpiling remdesivir is justified in light of the currently available evidence.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Adenosine Monophosphate
/
Internationality
/
Alanine
/
Strategic Stockpile
/
COVID-19 Drug Treatment
/
International Cooperation
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
J Comp Eff Res
Year:
2020
Document Type:
Article
Affiliation country:
Cer-2020-0174
Similar
MEDLINE
...
LILACS
LIS